Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 68071-5292

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-5292). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 5292 9)

This text is a prescription label for Atorvastatin Calcium 20mg tablets from NuCare Pharmaceuticals, Inc. It includes information about the medication, such as the National Drug Code (NDC) number, quantity, manufacturer details, dosing instructions, and storage recommendations. It also emphasizes the importance of keeping the medication out of reach of children and storing it at a controlled temperature.*

FDA Label Image

Atorvastatin-figure-01 (Atorvastatin Figure 01)

This is a chart displaying cumulative incidence percentage for Atorvastatin and Placebo over a span of 25, 30, and 35 years. The cumulative incidence percentages are 40% and 30%, respectively.*

FDA Label Image

Atorvastatin-figure-02 (Atorvastatin Figure 02)

This is a comparison between Placebo and Atorvastatin in terms of cumulative hazard percentage over a 4-year follow-up period. The hazard ratio for Atorvastatin compared to Placebo is 0.63 with a confidence interval of 0.48-0.83 and a p-value of 0.001. The graph shows the time to the first primary endpoint for both treatments.*

FDA Label Image

Atorvastatin-figure-03 (Atorvastatin Figure 03)

This text provides information related to the drug Atorvastatin in dosages of 10 mg and 80 mg, along with statistical results displayed as HRO (Hazard Ratio Odds) of 0.78 with a confidence interval of 0.69-0.89 and a p-value of 0.0002. The data seems to pertain to the time taken to reach the first major cardiovascular endpoint in years.*

FDA Label Image

Structure (Atorvastatin Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.